更正 "妊娠期使用缓释丁丙诺啡"。

IF 2.5 4区医学 Q2 SUBSTANCE ABUSE

American Journal on Addictions Pub Date : 2024-11-17 DOI:10.1111/ajad.13667

{"title":"更正 \"妊娠期使用缓释丁丙诺啡\"。","authors":"","doi":"10.1111/ajad.13667","DOIUrl":null,"url":null,"abstract":"Hubbell A, Aghenta E, Jones C, Specker S. Extended-release buprenorphine in pregnancy. Am J Addict. 2024;33:354-356.In the above article, Reference #1 was incorrect. The incorrect reference read:Haight BR, Learned SM, Laffont CM, et al. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019; 393(10173): 778-790. doi:10.1016/S0140-6736(18)32259-1This correct reference is:Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr. mm6731a1We apologize for this error.","PeriodicalId":7762,"journal":{"name":"American Journal on Addictions","volume":"34 3","pages":"367"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajad.13667","citationCount":"0","resultStr":"{\"title\":\"Correction to “Extended-release buprenorphine in pregnancy”\",\"authors\":\"\",\"doi\":\"10.1111/ajad.13667\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hubbell A, Aghenta E, Jones C, Specker S. Extended-release buprenorphine in pregnancy. Am J Addict. 2024;33:354-356.In the above article, Reference #1 was incorrect. The incorrect reference read:Haight BR, Learned SM, Laffont CM, et al. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019; 393(10173): 778-790. doi:10.1016/S0140-6736(18)32259-1This correct reference is:Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr. mm6731a1We apologize for this error.\",\"PeriodicalId\":7762,\"journal\":{\"name\":\"American Journal on Addictions\",\"volume\":\"34 3\",\"pages\":\"367\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajad.13667\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal on Addictions\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ajad.13667\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal on Addictions","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ajad.13667","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

摘要

张建军，张建军，张建军，等。丁丙诺啡缓释剂在妊娠期的应用。[J] .中华医学杂志。2009;33:354-356。在上述文章中，参考文献1是不正确的。错误的参考文献是：Haight BR、Learned SM、Laffont CM等。每月一次丁丙诺啡储存注射治疗阿片类药物使用障碍的有效性和安全性：一项多中心、随机、双盲、安慰剂对照的3期试验柳叶刀》。2019;393(10173): 778 - 790。正确的参考文献是：Haight SC， Ko JY, Tong VT, Bohm MK, Callaghan WM。1999-2014年美国分娩住院时记录的阿片类药物使用障碍医学杂志2018年8月10日；67(31):845-849。doi: 10.15585 / mmwr。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Extended-release buprenorphine in pregnancy”

Hubbell A, Aghenta E, Jones C, Specker S. Extended-release buprenorphine in pregnancy. Am J Addict. 2024;33:354-356.

In the above article, Reference #1 was incorrect. The incorrect reference read:

Haight BR, Learned SM, Laffont CM, et al. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019; 393(10173): 778-790. doi:10.1016/S0140-6736(18)32259-1

This correct reference is:

Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr. mm6731a1

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal on Addictions SUBSTANCE ABUSE-

CiteScore

5.00

自引率

0.00%

发文量

118

期刊介绍： The American Journal on Addictions is the official journal of the American Academy of Addiction Psychiatry. The Academy encourages research on the etiology, prevention, identification, and treatment of substance abuse; thus, the journal provides a forum for the dissemination of information in the extensive field of addiction. Each issue of this publication covers a wide variety of topics ranging from codependence to genetics, epidemiology to dual diagnostics, etiology to neuroscience, and much more. Features of the journal, all written by experts in the field, include special overview articles, clinical or basic research papers, clinical updates, and book reviews within the area of addictions.